The CURE project (full title “Constructing a ‘Eubiosis Reinstatement Therapy’ for Asthma” is proposing a phage therapy that could control the immune dysregulation of the disease and may eventually be able to cure it. CURE receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 767015.

Novelty and

foundational character

Read More

Impact on

future leadership

Read More

Long term vision

Read More

More than 30 million Europeans currently suffer from asthma. In the last few decades asthma prevalence and burden have increased to pandemic proportions. Several of the countries with the highest burden are in Europe, with more than 1 in 4 children affected.